Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Relay Therapeutics Inc (NQ: RLAY ) 6.440 -0.120 (-1.83%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Relay Therapeutics Inc < Previous 1 2 3 4 5 6 7 Next > Evogene Offers An Excellent Risk/Reward Ratio March 21, 2023 We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their... Via Talk Markets Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR March 06, 2023 Relay Therapeutics to host conference call following AACR presentation From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics's Return On Capital Employed Overview March 01, 2023 Via Benzinga Relay Therapeutics to Participate in Two Upcoming Investor Conferences March 01, 2023 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics Earnings Preview February 22, 2023 Via Benzinga 5 Analysts Have This to Say About Relay Therapeutics September 30, 2022 Relay Therapeutics (NASDAQ:RLAY) has observed the following analyst ratings within the last quarter: Via Benzinga Expert Ratings for Relay Therapeutics September 30, 2022 Within the last quarter, Relay Therapeutics (NASDAQ:RLAY) has observed the following analyst ratings: Via Benzinga Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights February 23, 2023 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights February 16, 2023 From Relay Therapeutics, Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023 February 03, 2023 Via Benzinga 4 Analysts Have This to Say About Relay Therapeutics September 14, 2022 Within the last quarter, Relay Therapeutics (NASDAQ:RLAY) has observed the following analyst ratings: Via Benzinga Earnings Scheduled For February 23, 2023 February 23, 2023 Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. Via Benzinga Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day February 02, 2023 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference January 03, 2023 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics to Participate in Two Upcoming Investor Conferences November 07, 2022 From Relay Therapeutics, Inc. Via GlobeNewswire Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session December 19, 2022 Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. Via Benzinga Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights November 03, 2022 From Relay Therapeutics, Inc. Via GlobeNewswire Earnings Scheduled For November 3, 2022 November 03, 2022 Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. Via Benzinga Relay Therapeutics's Earnings Outlook November 02, 2022 Relay Therapeutics (NASDAQ:RLAY) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Relay... Via Benzinga Relay Therapeutics to Announce Third Quarter 2022 Financial Results and Corporate Highlights October 27, 2022 From Relay Therapeutics, Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022 September 30, 2022 Upgrades Via Benzinga 7 Unknown Biotech Stocks That Could Rocket in 2023 September 23, 2022 Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline. Via InvestorPlace Wells Fargo Slashes Price Target On This Stock By Over 71%, Also Check Out Other Major PT Changes Here September 14, 2022 Wells Fargo cut the price target on Cabaletta Bio, Inc. (NASDAQ: CABA) from $14 to $4. Wells Fargo analyst Derek Archila maintained the stock with an Overweight rating. Cabaletta Bio shares gained 0.9%... Via Benzinga Tesla, Meta, NVIDIA And Other Big Losers From Tuesday September 14, 2022 U.S. stocks closed sharply lower with the Nasdaq Composite dipping more than 5% on Tuesday. Here is the list of some big stocks moving lower in the previous session. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session September 13, 2022 Via Benzinga Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday September 14, 2022 Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX... Via Benzinga Why Relay Therapeutics Shares Are Getting Hammered September 13, 2022 Relay Therapeutics Inc (NASDAQ: RLAY) shares are trading lower by 11.33% to $25.54 Tuesday morning after the company priced a roughly 11.32 million share public offering of common stock at $26.50 per... Via Benzinga Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session September 13, 2022 Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis. Via Benzinga Relay Therapeutics, Rent the Runway And Some Other Big Stocks Moving Lower In Today's Pre-Market Session September 13, 2022 U.S. stock futures traded higher this morning ahead of the much-awaited inflation data for August. Here are some big stocks moving lower in today’s pre-market trading session. Via Benzinga Why SeaChange International Is Trading Higher By Around 15%; Here Are 26 Stocks Moving Premarket September 13, 2022 Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) rose 41.7% to $2.72 in pre-market trading. Comera Life Sciences Form 4 filing showed multiple insiders purchased 122,600 shares at an average... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.